BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25325686)

  • 1. Sculpting the proteome with small molecules.
    King RW; Finley D
    Nat Chem Biol; 2014 Nov; 10(11):870-4. PubMed ID: 25325686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.
    Akinjiyan FA; Carbonneau S; Ross NT
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4589-4596. PubMed ID: 28911816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonconformity in ubiquitin compliance.
    Ziv I; Kleifeld O; Glickman M
    EMBO J; 2009 Jul; 28(13):1825-7. PubMed ID: 19587678
    [No Abstract]   [Full Text] [Related]  

  • 4. Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.
    Buckley DL; Crews CM
    Angew Chem Int Ed Engl; 2014 Feb; 53(9):2312-30. PubMed ID: 24459094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Modulation of Protein Homeostasis.
    Burslem GM; Crews CM
    Chem Rev; 2017 Sep; 117(17):11269-11301. PubMed ID: 28777566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
    Ao N; Chen Q; Liu G
    Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of the 19S complex in proteasomal degradation.
    Liu CW; Jacobson AD
    Trends Biochem Sci; 2013 Feb; 38(2):103-10. PubMed ID: 23290100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Discovery to Bedside: Targeting the Ubiquitin System.
    Wertz IE; Wang X
    Cell Chem Biol; 2019 Feb; 26(2):156-177. PubMed ID: 30554913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-Molecule Stimulators of NRF1 Transcriptional Activity.
    Iaconelli J; Ibrahim L; Chen E; Hull M; Schultz PG; Bollong MJ
    Chembiochem; 2020 Jul; 21(13):1816-1819. PubMed ID: 31596542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound.
    Giovannucci TA; Salomons FA; Haraldsson M; Elfman LHM; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson AL; Johnsen JI; Dantuma NP
    Cell Death Dis; 2021 Oct; 12(10):914. PubMed ID: 34615851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation: a novel protein quality control modifier in the heart.
    Maejima Y; Sadoshima J
    Circ Res; 2014 Sep; 115(8):686-9. PubMed ID: 25258400
    [No Abstract]   [Full Text] [Related]  

  • 12. Processive ubiquitin chain formation by the anaphase-promoting complex.
    Meyer HJ; Rape M
    Semin Cell Dev Biol; 2011 Aug; 22(6):544-50. PubMed ID: 21477659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of E2-25K/UBB+1 interaction leading to proteasome inhibition and neurotoxicity.
    Ko S; Kang GB; Song SM; Lee JG; Shin DY; Yun JH; Sheng Y; Cheong C; Jeon YH; Jung YK; Arrowsmith CH; Avvakumov GV; Dhe-Paganon S; Yoo YJ; Eom SH; Lee W
    J Biol Chem; 2010 Nov; 285(46):36070-80. PubMed ID: 20826778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted protein degradation and the enzymology of degraders.
    Fisher SL; Phillips AJ
    Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.
    Dalla Via L; Nardon C; Fregona D
    Future Med Chem; 2012 Mar; 4(4):525-43. PubMed ID: 22416778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hip2 interacts with cyclin B1 and promotes its degradation through the ubiquitin proteasome pathway.
    Bae Y; Choi D; Rhim H; Kang S
    FEBS Lett; 2010 Nov; 584(22):4505-10. PubMed ID: 20965177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ubiquitin-proteasome system.
    Nandi D; Tahiliani P; Kumar A; Chandu D
    J Biosci; 2006 Mar; 31(1):137-55. PubMed ID: 16595883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and Function of the 26S Proteasome.
    Bard JAM; Goodall EA; Greene ER; Jonsson E; Dong KC; Martin A
    Annu Rev Biochem; 2018 Jun; 87():697-724. PubMed ID: 29652515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR characterization of the interaction between the PUB domain of peptide:N-glycanase and ubiquitin-like domain of HR23.
    Kamiya Y; Uekusa Y; Sumiyoshi A; Sasakawa H; Hirao T; Suzuki T; Kato K
    FEBS Lett; 2012 Apr; 586(8):1141-6. PubMed ID: 22575648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdc48-Ufd2-Rad23: the road less ubiquitinated?
    Bazirgan OA; Hampton RY
    Nat Cell Biol; 2005 Mar; 7(3):207-9. PubMed ID: 15738968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.